Skip Navigation


JAC Advance Access originally published online on November 28, 2005
Journal of Antimicrobial Chemotherapy 2006 57(1):151-152; doi:10.1093/jac/dki415
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/1/151    most recent
dki415v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cornely, O. A.
Right arrow Articles by Karthaus, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cornely, O. A.
Right arrow Articles by Karthaus, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

Comment on: Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies

Oliver A. Cornely1,*, Andrew J. Ullmann2 and Meinolf Karthaus3

1 Klinik I für Innere Medizin, Klinikum der Universität Köln, Köln, Germany; 2 Medizinische Klinik III, Johannes Gutenberg Universität, Mainz, Germany; 3 Medizinische Klinik II, Ev. Johannes-Krankenhaus, Bielefeld, Germany

* Corresponding author. E-mail: oliver.cornely@uni-koeln.de

Keywords: antifungals , prophylaxis , meta-analysis

The first 10% of the full text of this article appears below.

Sir,

A recently published JAC review claims to have found ‘unambiguous evidence’ in the field of antifungal prophylaxis.1 In our view this topic is too complex to allow such a simple conclusion. This review by Glasmacher et al. shows several short comings that require further comment and some additional clarification.

In . . . [Full Text of this Article]

Transparency declarations


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
A. Glasmacher and A. Prentice
The role of meta-analysis in the evaluation of antifungal prophylaxis: authors' response
J. Antimicrob. Chemother., January 1, 2006; 57(1): 152 - 154.
[Full Text] [PDF]